These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1696539)
1. Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells. Schols D; Pauwels R; Desmyter J; De Clercq E Cytometry; 1990; 11(6):736-43. PubMed ID: 1696539 [TBL] [Abstract][Full Text] [Related]
2. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry. Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268 [TBL] [Abstract][Full Text] [Related]
3. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. Baba M; Schols D; Pauwels R; Nakashima H; De Clercq E J Acquir Immune Defic Syndr (1988); 1990; 3(5):493-9. PubMed ID: 1691288 [TBL] [Abstract][Full Text] [Related]
4. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Schols D; Pauwels R; Desmyter J; De Clercq E Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563 [TBL] [Abstract][Full Text] [Related]
5. Maleylated human serum albumin inhibits HIV-1 infection in vitro. Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431 [TBL] [Abstract][Full Text] [Related]
6. HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro. Busso M; Thornthwaite J; Resnick L AIDS; 1991 Dec; 5(12):1425-32. PubMed ID: 1687645 [TBL] [Abstract][Full Text] [Related]
7. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells. Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474 [TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity. Konopka K; Pretzer E; Celada F; Düzgüneş N J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355 [TBL] [Abstract][Full Text] [Related]
9. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. Cushman M; Wang PL; Chang SH; Wild C; De Clercq E; Schols D; Goldman ME; Bowen JA J Med Chem; 1991 Jan; 34(1):329-37. PubMed ID: 1704065 [TBL] [Abstract][Full Text] [Related]
10. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. Crowe SM; Mills J; Kirihara J; Boothman J; Marshall JA; McGrath MS AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1031-7. PubMed ID: 1977427 [TBL] [Abstract][Full Text] [Related]
12. Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120. Weaver JL; Gergely P; Pine PS; Patzer E; Aszalos A AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1125-30. PubMed ID: 1979910 [TBL] [Abstract][Full Text] [Related]
13. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664 [TBL] [Abstract][Full Text] [Related]
15. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. Lederman S; Gulick R; Chess L J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782 [TBL] [Abstract][Full Text] [Related]
16. Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains. Yelle J; Morisset R; Thibodeau L Arch Virol; 1994; 139(1-2):155-72. PubMed ID: 7826207 [TBL] [Abstract][Full Text] [Related]
17. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1). Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells. Martin SJ; Matear PM; Vyakarnam A J Immunol; 1994 Jan; 152(1):330-42. PubMed ID: 7902858 [TBL] [Abstract][Full Text] [Related]
19. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity. Konopka K; Pretzer E; Düzgünes N Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]